Overview

Efficacy Study of Pioglitazone and Glimepiride on the Rate of Progression of Atherosclerotic Disease.

Status:
Completed
Trial end date:
2006-05-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to compare the effects of pioglitazone, once daily (QD), versus glimepiride on the amount of thickening of the carotid artery.
Phase:
Phase 3
Details
Lead Sponsor:
Takeda
Treatments:
Glimepiride
Pioglitazone